JF
REGN icon

Jump Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Jump Financial’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
+16,242
New +$11.1M 0.08% 272
2026
Q1 		– Sell
-1,554
Closed -$1.2M – 2319
2025
Q4 		$1.2M Sell
1,554
-9,160
-85% -$6.22M 0.01% 905
2025
Q3 		$6.02M Buy
10,714
+5,140
+92% +$2.91M 0.07% 352
2025
Q2 		$2.93M Sell
5,574
-38,854
-87% -$21.7M 0.03% 591
2025
Q1 		$28.2M Buy
44,428
+25,634
+136% +$17.6M 0.37% 58
2024
Q4 		$13.4M Buy
18,794
+17,586
+1,456% +$14.8M 0.28% 77
2024
Q3 		$1.27M Sell
1,208
-4,882
-80% -$5.43M 0.03% 691
2024
Q2 		$6.4M Buy
6,090
+1,604
+36% +$1.55M 0.13% 172
2024
Q1 		$4.32M Sell
4,486
-3,746
-46% -$3.56M 0.12% 163
2023
Q4 		$7.23M Buy
8,232
+5,728
+229% +$4.72M 0.23% 65
2023
Q3 		$2.06M Buy
2,504
+1,259
+101% +$989K 0.08% 356
2023
Q2 		$895K Buy
+1,245
New +$960K 0.03% 734
2022
Q4 		– Sell
-944
Closed -$650K – 1958
2022
Q3 		$650K Buy
+944
New +$594K 0.03% 784
2022
Q2 		– Sell
-613
Closed -$428K – 1958
2022
Q1 		$428K Sell
613
-606
-50% -$383K 0.02% 885
2021
Q4 		$769K Buy
+1,219
New +$749K 0.05% 482
2021
Q3 		– Sell
-3,278
Closed -$1.83M – 1436
2021
Q2 		$1.83M Buy
3,278
+2,515
+330% +$1.27M 0.18% 126
2021
Q1 		$361K Buy
+763
New +$371K 0.03% 532

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jump Financial's REGN Position: Q2 2026 in Review

Jump Financial opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 16,242 shares worth $10.1M. The stake represents 0.08% of the portfolio and ranks #272 among its holdings. This is a return to the name: Jump Financial previously reported a position in REGN as recently as Q4 2025.

Jump Financial first reported a position in REGN in Q1 2021 and has held it in 17 quarters since. The position peaked at $28.2M in Q1 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Jump Financial held 16,242 shares of Regeneron Pharmaceuticals worth $10.1M as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Jump Financial position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.08% of Jump Financial's portfolio in Q2 2026, its #272 holding.
  • Jump Financial first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
  • Jump Financial's Regeneron Pharmaceuticals position peaked at $28.2M in Q1 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.